RNTX
Rein Therapeutics, Inc.
+0.08 (+11.68%)0.78USD130K成交股數67.6M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.6M | 3.1M | 1.7M | 4.3M | 3.1M | 3.3M | 3.7M | 3.7M | 3.5M | 22K | 187K | 1.8M |
| 銷售管理費用 | 2.4M | 2.2M | 3.8M | 2.6M | 2.6M | 2.5M | 2.3M | 5.3M | 3.7M | 2.0M | 1.9M | 2.2M |
| 營業利益 | −6.1M+8% | −5.2M-88% | −5.5M-10% | −6.9M-24% | −5.6M-22% | −42.8M+2058% | −6.1M+205% | −9.0M+80% | −7.2M | −2.0M | −2.0M | −5.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −6.4M+16% | −5.8M-86% | −5.6M-5% | −6.8M-24% | −5.5M-23% | −41.0M+2144% | −5.8M+227% | −8.9M+87% | −7.1M | −1.8M | −1.8M | −4.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.10-60% | -0.19-90% | -0.21-22% | -0.28-38% | -0.25-71% | -1.93+382% | -0.27-31% | -0.45-57% | -0.86 | -0.40 | -0.39 | -1.05 |
| 稀釋股數 | 67.1M | 30.4M | 26.4M | 24.2M | 21.9M | 17.9M | 21.7M | 19.9M | 8.3M | 4.5M | 4.5M | 4.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.5M | 4.4M | 4.0M | 5.7M | 7.4M | 12.9M | 17.7M | 21.9M | 12.0M | 12.1M | 13.2M | 7.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 66.0M | 26.3M | 53.7M | 57.5M | 57.6M | 62.2M | 104M | 109M | 99.2M | 12.8M | 14.0M | 17.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.8M | 14.7M | 7.5M | 9.5M | 7.7M | 7.8M | 9.0M | 8.4M | 7.9M | 1.6M | 1.2M | 2.9M |
| 股東權益 | 55.2M | 11.6M | 46.2M | 48.0M | 49.9M | 54.4M | 95.2M | 101M | 91.3M | 11.2M | 12.8M | 14.3M |
| 負債比 | 16.3% | 55.9% | 14.0% | 16.5% | 13.4% | 12.5% | 8.6% | 7.7% | 7.9% | 12.7% | 8.6% | 16.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.4M | – | – | −6.2M+17% | – | – | – | −5.3M | – | – | −4.7M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | 0 | – | – | – | 59K | – | – | 43K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0 | – | −49.9M | –% | -1.96 | – |
| FY2024 | 0 | – | −62.9M | –% | -3.51 | – |
| FY2023 | 0 | – | −15.7M | –% | -3.42 | – |
| FY2022 | 0 | – | −27.3M | –% | -6.02 | – |
| FY2021 | 0 | – | −26.2M | –% | -5.89 | −23.9M |
| FY2020 | 0 | – | −27.3M | –% | -0.61 | −20.5M |
| FY2019 | 0 | – | −29.4M | –% | -1.20 | −26.6M |
| FY2018 | 0 | – | −31.5M | –% | -2.14 | −32.3M |